Concepedia

Author

Amy P. Abernethy

Duke Medical CenterORCID

Also Known As

A Abernethy, A P Abernethy, A. Abernethy, A. P. Abernethy, A.P. Abernethy, AMY ABERNETHY, AMY P. ABERNETHY, AP Abernethy, Abernethy, A. P., Abernethy, Amy

738

Publications

35.3K

Citations

92

H-Index

253

Concepts

All Affiliations

Duke Medical CenterDuke UniversityFlinders UniversityClinical Research InstituteDuke University Hospital
AP

About

Amy P. Abernethy is an author at Duke Medical Center specializing in medicine, oncology, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

19

24

1.7K

2

Arts

2

2

171

3

Engineering

2

2

1K

4

Language Studies

2

2

74

5

Business

1

1

287

Amy P. Abernethy

×

279

Publications

28.2K

Citations

80

H-Index

YearCitations

Generalist plus Specialist Palliative Care — Creating a More Sustainable Model

Timothy E. Quill, Amy P. Abernethy

New England Journal of Medicine

2013

1.4K

American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care

Thomas J. Smith, Sarah Temin, Erin R. Alesi,

Journal of Clinical Oncology

2012

1.3K

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell,

JNCI Journal of the National Cancer Institute

2014

1.1K

The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

S. Yousuf Zafar, Jeffrey Peppercorn, Deborah Schrag,

The Oncologist

2013

1.1K

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell,

JAMA Oncology

2015

979

Mobile Health Technology Evaluation

Santosh Kumar, Wendy Nilsen, Amy P. Abernethy,

American Journal of Preventive Medicine

2013

924

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Jennifer S. Temel, Amy P. Abernethy, David C. Currow,

The Lancet Oncology

2016

607

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

Gaurav Singal, Peter G. Miller, Vineeta Agarwala,

JAMA

2019

541

Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea

Amy P. Abernethy

BMJ

2003

514

The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]

Amy P. Abernethy, Tania Shelby‐James, Belinda Fazekas,

BMC Palliative Care

2005

503

Page 1